Fraser Henderson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Fraser Henderson has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Theodore H. Schwartz
Weill Cornell Medical College
3 shared publications Cristian Vera
Department of Neurosurgery, Medical University of South Carolina, Charleston, SC, USA
2 shared publicationsSteven Brem
Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
2 shared publicationsSunil J. Patel
Department of Neurosurgery, Medical University of South Carolina, Charleston, SC, USA
2 shared publicationsSunil Patel
A Department of Neurosurgery , Medical University of South Carolina , Charleston , South Carolina , USA
2 shared publications- William R. Copeland
Department of Neurosurgery, Kijabe Hospital, Kijabe, Kenya
2 shared publications
Latest Publications
- Open Access
- 29 May 2024
- Published by Springer Nature in Egyptian Journal of Neurosurgery
- Vol. 39 (1) , 1-2
Letter to the editor: additional considerations for giant pituitary adenoma resection strategy
- 29 May 2024
- Published by Springer Nature in Egyptian Journal of Neurosurgery
- Vol. 39 (1) , 1-2
Open AccessLetter to the editor: additional considerations for giant pituitary adenoma resection strategy
- 10 January 2023
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 92 (3) , e46-e47
Commentary: Complementary and Alternative Medicine for Gliomas: Systematic Review and Critical Appraisal of Current Literature
- 10 January 2023
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 92 (3) , e46-e47
Commentary: Complementary and Alternative Medicine for Gliomas: Systematic Review and Critical Appraisal of Current Literature
- 16 June 2022
- Published by Springer Nature in Pituitary
- Vol. 25 (4) , 551-562
Surgical strategies in the treatment of MR-negative Cushing’s Disease: a systematic review and treatment algorithm
Purpose Several surgical strategies have been proposed to treat MRI-negative Cushing’s Disease. These include tumor removal, if identified, and if a tumor is not identified, resection of varying degrees of the pituitary gland, often guided by inferior petrosal sinus sampling (IPSS). The relative risks and benefits of each strategy have never been compared. Methods This systematic review of the literature included only studies on the results of surgery for MRI-negative patients with Cushing’s Disease in which the surgical strategy was clearly described and associated remission and/or hypopituitarism rates detailed for each strategy. Results We identified 12 studies that met inclusion criteria for remission rates and 5 studies for hypopituitarism rates. We divided cases into 6 resection strategies. Remission and hypopituitarism rates for each strategy were: (1) tumor identified, resect tumor only (68%, 0%); (2) resect tumor and surrounding capsule (85%, 0%); and if the tumor was not identified (3) resect inferior 1/3 of gland (78%, no data); (4) resect 30–50% of gland based on IPSS (68%, 13%); (5) resect > 50% but < 100% of gland (65%, 9%); (6) resect entire gland (66%, 67%). Strategy 3 only contained 9 patients. Conclusion Remission rates for MRI-negative Cushing’s Disease support surgery as a reasonable approach. Results are best if a tumor is found. If a tumor is not identified, one can either remove one-third of the gland guided by IPSS lateralization, or remove both lateral portions along with the inferior portion leaving sufficient central gland to preserve function. Our recommendations are limited by the lack of rigorous and objective data.
- 16 June 2022
- Published by Springer Nature in Pituitary
- Vol. 25 (4) , 551-562
Surgical strategies in the treatment of MR-negative Cushing’s Disease: a systematic review and treatment algorithm
Purpose Several surgical strategies have been proposed to treat MRI-negative Cushing’s Disease. These include tumor removal, if identified, and if a tumor is not identified, resection of varying degrees of the pituitary gland, often guided by inferior petrosal sinus sampling (IPSS). The relative risks and benefits of each strategy have never been compared. Methods This systematic review of the literature included only studies on the results of surgery for MRI-negative patients with Cushing’s Disease in which the surgical strategy was clearly described and associated remission and/or hypopituitarism rates detailed for each strategy. Results We identified 12 studies that met inclusion criteria for remission rates and 5 studies for hypopituitarism rates. We divided cases into 6 resection strategies. Remission and hypopituitarism rates for each strategy were: (1) tumor identified, resect tumor only (68%, 0%); (2) resect tumor and surrounding capsule (85%, 0%); and if the tumor was not identified (3) resect inferior 1/3 of gland (78%, no data); (4) resect 30–50% of gland based on IPSS (68%, 13%); (5) resect > 50% but < 100% of gland (65%, 9%); (6) resect entire gland (66%, 67%). Strategy 3 only contained 9 patients. Conclusion Remission rates for MRI-negative Cushing’s Disease support surgery as a reasonable approach. Results are best if a tumor is found. If a tumor is not identified, one can either remove one-third of the gland guided by IPSS lateralization, or remove both lateral portions along with the inferior portion leaving sufficient central gland to preserve function. Our recommendations are limited by the lack of rigorous and objective data.
- 1 March 2022
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 22 (5) , e224
Transorbital Endoscopic Eyelid Approach for Resection of Spheno-Orbital Meningioma: 2-Dimensional Operative Video
- 1 March 2022
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 22 (5) , e224
Transorbital Endoscopic Eyelid Approach for Resection of Spheno-Orbital Meningioma: 2-Dimensional Operative Video
- 22 November 2021
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 156 (1) , 97-108
Update on management of craniopharyngiomas
Purpose/introduction Craniopharyngiomas are locally-aggressive tumors arising along the hypothalamic-pituitary axis. Treatment is nuanced as a result of their proximity and adherence to vital neurovascular structures and responsiveness to surgery, radiation and, in some cases, chemotherapy. Methods We reviewed the literature discussing the current state of knowledge regarding craniopharyngioma biology and therapy. Results Recent advances in endoscopic endonasal surgery (EEA) have made surgery a safer and more effective option. While cure may be achieved with gross total resection (GTR), when felt to be too risky, a subtotal resection followed by radiation is often a more prudent strategy, particularly in children with hypothalamic invasion. Data on long-term outcome are mostly derived from older studies in which a craniotomy, rather than EEA, was performed. Long-term EEA outcome studies are lacking. Enhanced knowledge of the biological basis of papillary CPs has led to novel medical treatments for BRAFv600E variants that appear to be effective. Conclusion Endoscopic technology has improved surgical results for craniopharyngiomas and expanded the indications for the transsphenoidal approach. The goal of CP surgery goal is maximal safe resection to achieve cure, but subtotal resection and radiation may be equally effective. Early diagnosis of specific variants will facilitate enrollment in promising medical trials.
- 22 November 2021
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 156 (1) , 97-108
Update on management of craniopharyngiomas
Purpose/introduction Craniopharyngiomas are locally-aggressive tumors arising along the hypothalamic-pituitary axis. Treatment is nuanced as a result of their proximity and adherence to vital neurovascular structures and responsiveness to surgery, radiation and, in some cases, chemotherapy. Methods We reviewed the literature discussing the current state of knowledge regarding craniopharyngioma biology and therapy. Results Recent advances in endoscopic endonasal surgery (EEA) have made surgery a safer and more effective option. While cure may be achieved with gross total resection (GTR), when felt to be too risky, a subtotal resection followed by radiation is often a more prudent strategy, particularly in children with hypothalamic invasion. Data on long-term outcome are mostly derived from older studies in which a craniotomy, rather than EEA, was performed. Long-term EEA outcome studies are lacking. Enhanced knowledge of the biological basis of papillary CPs has led to novel medical treatments for BRAFv600E variants that appear to be effective. Conclusion Endoscopic technology has improved surgical results for craniopharyngiomas and expanded the indications for the transsphenoidal approach. The goal of CP surgery goal is maximal safe resection to achieve cure, but subtotal resection and radiation may be equally effective. Early diagnosis of specific variants will facilitate enrollment in promising medical trials.
- 29 April 2021
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 89 (2) , 246-256
Enhanced Fiber Tractography Using Edema Correction: Application and Evaluation in High-Grade Gliomas
BACKGROUND: A limitation of diffusion tensor imaging (DTI)-based tractography is peritumoral edema that confounds traditional diffusion-based magnetic resonance metrics. OBJECTIVE: To augment fiber-tracking through peritumoral regions by performing novel edema correction on clinically feasible DTI acquisitions and assess the accuracy of the fiber-tracks using intraoperative stimulation mapping (ISM), task-based functional magnetic resonance imaging (fMRI) activation maps, and postoperative follow-up as reference standards. METHODS: Edema correction, using our bi-compartment free water modeling algorithm (FERNET), was performed on clinically acquired DTI data from a cohort of 10 patients presenting with suspected high-grade glioma and peritumoral edema in proximity to and/or infiltrating language or motor pathways. Deterministic fiber-tracking was then performed on the corrected and uncorrected DTI to identify tracts pertaining to the eloquent region involved (language or motor). Tracking results were compared visually and quantitatively using mean fiber count, voxel count, and mean fiber length. The tracts through the edematous region were verified based on overlay with the corresponding motor or language task-based fMRI activation maps and intraoperative ISM points, as well as at time points after surgery when peritumoral edema had subsided. RESULTS: Volume and number of fibers increased with application of edema correction; concordantly, mean fractional anisotropy decreased. Overlay with functional activation maps and ISM-verified eloquence of the increased fibers. Comparison with postsurgical follow-up scans with lower edema further confirmed the accuracy of the tracts. CONCLUSION: This method of edema correction can be applied to standard clinical DTI to improve visualization of motor and language tracts in patients with glioma-associated peritumoral edema.
- 29 April 2021
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 89 (2) , 246-256
Enhanced Fiber Tractography Using Edema Correction: Application and Evaluation in High-Grade Gliomas
BACKGROUND: A limitation of diffusion tensor imaging (DTI)-based tractography is peritumoral edema that confounds traditional diffusion-based magnetic resonance metrics. OBJECTIVE: To augment fiber-tracking through peritumoral regions by performing novel edema correction on clinically feasible DTI acquisitions and assess the accuracy of the fiber-tracks using intraoperative stimulation mapping (ISM), task-based functional magnetic resonance imaging (fMRI) activation maps, and postoperative follow-up as reference standards. METHODS: Edema correction, using our bi-compartment free water modeling algorithm (FERNET), was performed on clinically acquired DTI data from a cohort of 10 patients presenting with suspected high-grade glioma and peritumoral edema in proximity to and/or infiltrating language or motor pathways. Deterministic fiber-tracking was then performed on the corrected and uncorrected DTI to identify tracts pertaining to the eloquent region involved (language or motor). Tracking results were compared visually and quantitatively using mean fiber count, voxel count, and mean fiber length. The tracts through the edematous region were verified based on overlay with the corresponding motor or language task-based fMRI activation maps and intraoperative ISM points, as well as at time points after surgery when peritumoral edema had subsided. RESULTS: Volume and number of fibers increased with application of edema correction; concordantly, mean fractional anisotropy decreased. Overlay with functional activation maps and ISM-verified eloquence of the increased fibers. Comparison with postsurgical follow-up scans with lower edema further confirmed the accuracy of the tracts. CONCLUSION: This method of edema correction can be applied to standard clinical DTI to improve visualization of motor and language tracts in patients with glioma-associated peritumoral edema.
- 28 December 2020
- Published by Taylor & Francis in British Journal Of Neurosurgery
- Vol. 37 (5) , 1-2
A brief note on the plastic adaptability of the central nervous system
Dear sir, We read with interest the recent report ‘Motor cortex relocation after complete anatomical hemispherectomy for intractable epilepsy secondary to Rasmussen’s encephalitis’ 1 and we commend...
- 28 December 2020
- Published by Taylor & Francis in British Journal Of Neurosurgery
- Vol. 37 (5) , 1-2
A brief note on the plastic adaptability of the central nervous system
Dear sir, We read with interest the recent report ‘Motor cortex relocation after complete anatomical hemispherectomy for intractable epilepsy secondary to Rasmussen’s encephalitis’ 1 and we commend...
- 22 June 2020
- Published by Springer Nature in Child's Nervous System
- Vol. 37 (2) , 715-719
An online tumor board with international neurosurgical collaboration guides surgical decision-making in Western Kenya
Telecollaboration via web-based platforms has emerged as a tool to relieve constraints on the establishment of tumor boards for neurosurgical oncology. Challenging tumor cases arising in low- and middle-income countries may benefit from the use of such models. The case of a 5-year-old boy presenting in Western Kenya with a challenging tumor and symptomatic hydrocephalus was presented on a novel web platform to a multi-national audience of neurosurgeons. The treating neurosurgeon invited a physician network to review the case vignette and radiographic images. Respondents independently offered input during a prescribed response period. Three respondents provided surgical opinions during a 24-h response period. The treating neurosurgeon utilized the pooled input to determine a course of action for the patient. When a web-based platform is available, lone neurosurgeons in low-resource settings may nevertheless apply multi-national, multi-institutional perspectives to challenging oncology cases.
- 22 June 2020
- Published by Springer Nature in Child's Nervous System
- Vol. 37 (2) , 715-719
An online tumor board with international neurosurgical collaboration guides surgical decision-making in Western Kenya
Telecollaboration via web-based platforms has emerged as a tool to relieve constraints on the establishment of tumor boards for neurosurgical oncology. Challenging tumor cases arising in low- and middle-income countries may benefit from the use of such models. The case of a 5-year-old boy presenting in Western Kenya with a challenging tumor and symptomatic hydrocephalus was presented on a novel web platform to a multi-national audience of neurosurgeons. The treating neurosurgeon invited a physician network to review the case vignette and radiographic images. Respondents independently offered input during a prescribed response period. Three respondents provided surgical opinions during a 24-h response period. The treating neurosurgeon utilized the pooled input to determine a course of action for the patient. When a web-based platform is available, lone neurosurgeons in low-resource settings may nevertheless apply multi-national, multi-institutional perspectives to challenging oncology cases.
- 1 April 2020
- Published by Elsevier in World Neurosurgery
- Vol. 136, 172-177
The College of Surgeons of East, Central, and Southern Africa: Successes and Challenges in Standardizing Neurosurgical Training
- 1 April 2020
- Published by Elsevier in World Neurosurgery
- Vol. 136, 172-177
The College of Surgeons of East, Central, and Southern Africa: Successes and Challenges in Standardizing Neurosurgical Training
- Open Access
- 8 December 2019
- Published by Oxford University Press (OUP) in Neuro-Oncology Practice
- Vol. 7 (2) , 152-157
18F-Fluciclovine PET to distinguish treatment-related effects from disease progression in recurrent glioblastoma: PET fusion with MRI guides neurosurgical sampling
Differentiation of true tumor progression from treatment-related effects remains a major unmet need in caring for patients with glioblastoma. Here, we report how the intraoperative combination of MRI with18F-fluciclovine PET guided surgical sampling in 2 patients with recurrent glioblastoma.18F-Fluciclovine PET is FDA approved for use in prostate cancer and carries an orphan drug designation in glioma. To investigate its utility in recurrent glioblastoma, we fused PET and MRI images using 2 different surgical navigation systems and performed targeted stereotactic biopsies from the areas of high (“hot”) and low (“cold”) radiotracer uptake. Concordant histopathologic and imaging findings suggest that a combined18F-fluciclovine PET-MRI–guided approach can guide neurosurgical resection of viable recurrent glioblastoma in the background of treatment-related effects, which can otherwise look similar on MRI.
- 8 December 2019
- Published by Oxford University Press (OUP) in Neuro-Oncology Practice
- Vol. 7 (2) , 152-157
Open Access18F-Fluciclovine PET to distinguish treatment-related effects from disease progression in recurrent glioblastoma: PET fusion with MRI guides neurosurgical sampling
Differentiation of true tumor progression from treatment-related effects remains a major unmet need in caring for patients with glioblastoma. Here, we report how the intraoperative combination of MRI with18F-fluciclovine PET guided surgical sampling in 2 patients with recurrent glioblastoma.18F-Fluciclovine PET is FDA approved for use in prostate cancer and carries an orphan drug designation in glioma. To investigate its utility in recurrent glioblastoma, we fused PET and MRI images using 2 different surgical navigation systems and performed targeted stereotactic biopsies from the areas of high (“hot”) and low (“cold”) radiotracer uptake. Concordant histopathologic and imaging findings suggest that a combined18F-fluciclovine PET-MRI–guided approach can guide neurosurgical resection of viable recurrent glioblastoma in the background of treatment-related effects, which can otherwise look similar on MRI.